Weak R&D Ecosystem Will Undermine GCC’s Ambition For A Resilient Pharmaceutical Sector
Pharmaceuticals / Middle East / Tue 20 Feb, 2024
Key View
- GCC markets will need to promote a more conducive R&D environment to ensure a sustainable pharmaceutical sector.
- A greater focus on biotechnology will be necessary to build a self-sufficient sector and lower import reliance for innovative therapies.
- Due to deficiencies in R&D and specialised human capital, we remain cautious